About Us
Our Pipeline
Partner with Us
Newsroom
Careers
Contact
More
July 7, 2026
Uniquity Bio Welcomes Matthew Hartzell as Chief Financial Officer
October 29, 2025
Ep. 49 — TSLP and EoE: Exploring the Science Behind a Potential Treatment Target
July 14, 2025
Uniquity Bio Brings on Former Anthos Executive Will Kane as CEO
Uniquity Bio Welcomes Will Kane as President and CEO
June 25, 2025
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD
July 12, 2025
Philadelphia Makes Biggest Leap of Any City in 2025 Rankings of World's Top Startup Ecosystems
May 1, 2025
Uniquity Bio Welcomes Bill Meury as Chairman
April 30, 2025
Building Uniquity Bio: Teams, Capital, And Strategy
April 29, 2025
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
April 24, 2025
Giving promising drug compounds a second chance
March 12, 2025
25 Years in pharma: How one leader transforms companies and teams
January 2, 2025
A look at biotech's year of the megaround
December 31, 2024
Philly’s year in biopharma: a look back at 2024
December 9, 2024
Blackstone Eyes $5 Billion for Life Sciences Investments
September 19, 2024
Six immunology biotech companies revolutionizing immune treatments in 2024
July 3, 2024
In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024
May 28, 2024
Uniquity Bio's CEO on exiting stealth mode with $300M in funding from its parent Blackstone to go after TSLP in the I&I space
May 15, 2024
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation
